Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indomobil Sukses Internasional Tbk. (IMAS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Indomobil Sukses Internasional Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Indomobil Sukses Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indomobil Sukses Internasional Tbk. trades at Rp840 (market cap 3.34T, 162.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Indomobil Sukses Internasional Tbk. is far larger — about 20× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Indomobil Sukses Internasional Tbk. is more actively traded (162.9K versus 96.7K). Which is the better fit depends on your goals.

IMASOBAT
Market Cap
3.34T167.37B
Volume
162.9K96.7K
Lot
1.63K967
Turnover
137.15M23.82M
Average Price
841.95246.34
Value
137.15M23.82M
Indicative Equilibrium Price
840248
Indicative Equilibrium Volume
441

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IMAS
View details
OBAT
View details

About Indomobil Sukses Internasional Tbk.

PT Indomobil Sukses International Tbk (the Company) was initially established as a result of the merger between PT Indomulti Inti Industri Tbk (IMII) and PT Indomobil Investment corporation (IIC). The Company’s articles of association has been amended from time to time, most recently on June 30, 1999 in connection with the Company’s plans to offer shares with pre-emptive right. The Ministry of Justice has approved the amendment on July 5, 1999.

Read more on IMAS

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT